Zimmer Biomet Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $21.8 Billion 6/16 ABT
$196.8B		 SYK
$146.2B		 BSX
$145.4B		 MDT
$112.9B		 EW
$41.2B		 ZBH
$21.8B		 BIO
$9.6B		 GKOS
$8.6B		 BRKR
$8.6B		 ITGR
$4.7B		 CNMD
$2.1B		 NUVA
$2.1B		 OFIX
$692.8M		 SRDX
$527.2M		 CVRX
$427.5M		 LUNG
$247.2M
Gross Margin 70% 7/16 CVRX
85%		 EW
81%		 GKOS
77%		 SRDX
74%		 LUNG
74%		 NUVA
72%		 ZBH
70%		 BSX
69%		 OFIX
69%		 MDT
65%		 SYK
64%		 CNMD
57%		 ABT
56%		 BIO
55%		 BRKR
47%		 ITGR
16%
Profit Margin 14% 7/16 EW
100%		 BIO
100%		 ABT
15%		 MDT
15%		 SYK
15%		 CNMD
15%		 ZBH
14%		 BSX
11%		 BRKR
5%		 ITGR
5%		 NUVA
2%		 SRDX
-10%		 OFIX
-14%		 GKOS
-22%		 LUNG
-69%		 CVRX
-98%
EBITDA margin 29% 3/16 BIO
214%		 EW
30%		 ZBH
29%		 CNMD
21%		 SYK
20%		 NUVA
19%		 BSX
18%		 ABT
18%		 ITGR
8%		 MDT
0%		 SRDX
-2%		 OFIX
-6%		 BRKR
-9%		 GKOS
-26%		 LUNG
-69%		 CVRX
-123%
Quarterly Revenue $1.8 Billion 5/16 ABT
$10.6B		 MDT
$8.4B		 SYK
$5.5B		 BSX
$4.2B		 ZBH
$1.8B		 EW
$1.4B		 BRKR
$864.4M		 ITGR
$746.3M		 BIO
$649.7M		 NUVA
$317.8M		 CNMD
$316.7M		 OFIX
$196.6M		 GKOS
$96.7M		 SRDX
$33.2M		 LUNG
$20.4M		 CVRX
$13.4M
Quarterly Earnings $249.1 Million 7/16 EW
$3.1B 		ABT
$1.6B 		MDT
$1.3B 		SYK
$834.0M 		BIO
$653.2M 		BSX
$468.0M 		ZBH
$249.1M 		CNMD
$49.0M 		BRKR
$40.9M 		ITGR
$35.4M 		NUVA
$7.4M 		SRDX
-$3.4M 		CVRX
-$13.1M 		LUNG
-$14.1M 		GKOS
-$21.4M 		OFIX
-$27.4M
Quarterly Free Cash Flow $368.6 Million 3/16 SYK
$1.3B 		MDT
$554.0M 		ZBH
$368.6M 		EW
$319.9M 		BIO
$246.7M 		ITGR
$131.8M 		CNMD
$47.8M 		OFIX
$32.1M 		BRKR
$5.8M 		SRDX
$3.1M 		ABT
-$0 		NUVA
-$495,000 		LUNG
-$7.7M 		CVRX
-$10.4M 		GKOS
-$11.0M 		BSX
-$1.1T
Trailing 4 Quarters Revenue $5.8 Billion 7/16 BIO
$2.7T		 ABT
$41.2B		 MDT
$33.0B		 SYK
$22.0B		 BSX
$15.9B		 EW
$5.9B		 ZBH
$5.8B		 BRKR
$3.2B		 ITGR
$2.0B		 CNMD
$1.3B		 NUVA
$1.2B		 OFIX
$784.2M		 GKOS
$360.3M		 SRDX
$126.1M		 LUNG
$60.0M		 CVRX
$47.3M
Trailing 4 Quarters Earnings $664.3 Million 6/16 ABT
$10.6B 		MDT
$8.4B 		SYK
$5.5B 		BSX
$4.2B 		ZBH
$1.8B 		EW
$1.4B 		BRKR
$864.4M 		ITGR
$746.3M 		BIO
$649.7M 		NUVA
$317.8M 		CNMD
$316.7M 		OFIX
$196.6M 		GKOS
$96.7M 		SRDX
$33.2M 		LUNG
$20.4M 		CVRX
$13.4M
Quarterly Earnings Growth 53% 5/16 NUVA
925% 		EW
698% 		BIO
515% 		CNMD
209% 		ZBH
53% 		MDT
40% 		GKOS
30% 		ITGR
30% 		SYK
21% 		ABT
15% 		OFIX
5% 		LUNG
5% 		BSX
-7% 		CVRX
-45% 		BRKR
-54% 		SRDX
-152%
Annual Earnings Growth -16% 11/16 EW
218% 		CNMD
131% 		BSX
36% 		LUNG
32% 		MDT
31% 		SYK
24% 		OFIX
19% 		BRKR
18% 		ITGR
15% 		ABT
4% 		ZBH
-16% 		GKOS
-16% 		CVRX
-33% 		NUVA
-50% 		SRDX
-111% 		BIO
-18757%
Quarterly Revenue Growth 4% 12/16 CVRX
27% 		GKOS
24% 		BSX
19% 		SRDX
19% 		BRKR
16% 		LUNG
15% 		SYK
12% 		OFIX
7% 		ITGR
6% 		ABT
5% 		MDT
5% 		ZBH
4% 		CNMD
4% 		BIO
3% 		NUVA
2% 		EW
-9%
Annual Revenue Growth -21% 15/16 BIO
99740% 		CVRX
21% 		BRKR
16% 		GKOS
13% 		BSX
11% 		SYK
10% 		MDT
6% 		ITGR
6% 		OFIX
5% 		NUVA
4% 		ABT
3% 		CNMD
2% 		EW
-3% 		LUNG
-13% 		ZBH
-21% 		SRDX
-32%
Cash On Hand $569.0 Million 5/16 SYK
$3.9B 		EW
$3.7B 		BSX
$2.5B 		MDT
$1.4B 		ZBH
$569.0M 		BIO
$410.4M 		BRKR
$148.1M 		CVRX
$100.2M 		GKOS
$100.1M 		NUVA
$80.7M 		LUNG
$63.3M 		CNMD
$38.5M 		SRDX
$36.1M 		ITGR
$35.6M 		OFIX
$30.1M 		ABT
-$0
Short Term Debt $1.7 Billion 3/16 SYK
$13.3B 		MDT
$3.7B 		ZBH
$1.7B 		BSX
$1.7B 		NUVA
$360.8M 		BRKR
$32.8M 		EW
$24.2M 		ITGR
$13.9M 		OFIX
$7.0M 		BIO
$1.3M 		LUNG
$762,000 		CNMD
$717,000 		CVRX
$275,000 		ABT
-$0 		GKOS
-$0 		SRDX
-$0
Long Term Debt $4.9 Billion 4/16 MDT
$24.6B		 SYK
$13.3B		 BSX
$9.2B		 ZBH
$4.9B		 BRKR
$2.3B		 BIO
$1.2B		 ITGR
$1.2B		 CNMD
$940.1M		 EW
$682.5M		 NUVA
$545.4M		 GKOS
$157.1M		 OFIX
$130.2M		 LUNG
$55.0M		 CVRX
$50.2M		 SRDX
$29.6M		 ABT
$0
PE 32.83 6/16 BSX
81.28		 NUVA
73.28		 ITGR
41.65		 SYK
40.71		 ABT
34.13		 ZBH
32.83		 BRKR
28.28		 MDT
26.33		 CNMD
15.87		 EW
9.90		 GKOS
-1.00		 BIO
-1.00		 SRDX
-1.00		 OFIX
-1.00		 LUNG
-1.00		 CVRX
-1.00
PS 3.74 9/16 GKOS
23.93		 BSX
9.14		 CVRX
9.05		 EW
7.01		 SYK
6.65		 ABT
4.78		 SRDX
4.18		 LUNG
4.12		 ZBH
3.74		 MDT
3.42		 BRKR
2.66		 ITGR
2.35		 NUVA
1.70		 CNMD
1.62		 OFIX
0.88		 BIO
0.00
PB 1.76 13/16 GKOS
12.90		 BSX
6.94		 CVRX
6.56		 BRKR
4.68		 SRDX
4.43		 EW
4.28		 SYK
4.04		 ITGR
2.92		 LUNG
2.63		 NUVA
2.34		 MDT
2.32		 CNMD
2.24		 ZBH
1.76		 OFIX
1.32		 BIO
1.28		 ABT
0.00
PC 38.33 7/16 ITGR
132.95		 GKOS
86.11		 MDT
81.02		 BRKR
58.22		 BSX
58.12		 CNMD
54.36		 ZBH
38.33		 SYK
37.97		 NUVA
25.83		 BIO
23.39		 OFIX
23.05		 SRDX
14.60		 EW
11.19		 CVRX
4.27		 LUNG
3.90		 ABT
-1.00
Liabilities to Equity 0.75 9/16 BRKR
2.34		 CNMD
1.48		 NUVA
1.34		 CVRX
0.96		 ITGR
0.95		 MDT
0.85		 BSX
0.83		 LUNG
0.78		 ZBH
0.75		 OFIX
0.65		 SRDX
0.50		 BIO
0.42		 GKOS
0.39		 EW
0.35		 SYK
0.17		 ABT
0.00
ROA 0.03 8/16 EW
32% 		SYK
8% 		CNMD
6% 		BSX
5% 		MDT
5% 		BRKR
5% 		ITGR
4% 		ZBH
3% 		NUVA
1% 		SRDX
-6% 		OFIX
-14% 		GKOS
-16% 		LUNG
-26% 		CVRX
-46% 		ABT
-100% 		BIO
-6012%
ROE 0.05 8/16 EW
44% 		BRKR
17% 		CNMD
14% 		BSX
9% 		MDT
9% 		SYK
8% 		ITGR
7% 		ZBH
5% 		NUVA
3% 		SRDX
-10% 		GKOS
-22% 		OFIX
-23% 		LUNG
-46% 		CVRX
-90% 		ABT
-100% 		BIO
-8513%
Current Ratio 2.33 7/16 SYK
5.72		 EW
3.86		 GKOS
3.59		 BIO
3.40		 SRDX
2.99		 OFIX
2.54		 ZBH
2.33		 LUNG
2.28		 BSX
2.22		 MDT
2.18		 ITGR
2.05		 CVRX
2.04		 NUVA
1.75		 CNMD
1.67		 BRKR
1.43		 ABT
-1.00
Quick Ratio 0.06 11/16 BSX
81.28		 NUVA
73.28		 ITGR
41.65		 SYK
40.71		 ABT
34.13		 ZBH
32.83		 BRKR
28.28		 MDT
26.33		 CNMD
15.87		 EW
9.90		 GKOS
-1.00		 BIO
-1.00		 SRDX
-1.00		 OFIX
-1.00		 LUNG
-1.00		 CVRX
-1.00
Long Term Debt to Equity 0.39 9/16 BRKR}
1.24		 CNMD}
1.01		 CVRX}
0.77		 ITGR}
0.71		 NUVA}
0.61		 LUNG}
0.59		 MDT}
0.51		 BSX}
0.45		 ZBH}
0.39		 SYK}
0.30		 SRDX}
0.25		 OFIX}
0.25		 GKOS}
0.24		 BIO}
0.16		 EW}
0.07		 ABT}
-1.00
Debt to Equity 0.53 8/16 BRKR
1.26		 NUVA
1.02		 CNMD
1.01		 CVRX
0.77		 ITGR
0.72		 LUNG
0.59		 MDT
0.58		 ZBH
0.53		 BSX
0.53		 SYK
0.30		 OFIX
0.26		 SRDX
0.25		 GKOS
0.24		 BIO
0.16		 EW
0.07		 ABT
-1.00
Burn Rate 1.52 9/16 BSX
7.96		 SRDX
7.80		 CVRX
6.60		 LUNG
3.83		 GKOS
3.62		 BRKR
2.56		 ITGR
2.48		 MDT
2.16		 ZBH
1.52		 SYK
1.27		 OFIX
0.88		 NUVA
0.77		 ABT
0.00		 BIO
-0.68		 EW
-1.21		 CNMD
-3.43
Cash to Cap 0.03 8/16 LUNG
0.26		 CVRX
0.23		 EW
0.09		 SRDX
0.07		 NUVA
0.04		 BIO
0.04		 OFIX
0.04		 ZBH
0.03		 SYK
0.03		 BSX
0.02		 BRKR
0.02		 CNMD
0.02		 MDT
0.01		 GKOS
0.01		 ITGR
0.01		 ABT
0.00
CCR 1.48 3/16 ITGR
3.72		 SYK
1.56		 ZBH
1.48		 CNMD
0.98		 CVRX
0.80		 LUNG
0.54		 GKOS
0.52		 MDT
0.44		 BIO
0.38		 BRKR
0.14		 EW
0.10		 ABT
0.00		 NUVA
-0.07		 SRDX
-0.90		 OFIX
-1.17		 BSX
-2442.82
EV to EBITDA 51.94 6/16 BSX}
205.88		 SYK}
143.45		 ABT}
101.46		 ITGR}
101.10		 EW}
94.80		 ZBH}
51.94		 NUVA}
47.54		 CNMD}
45.56		 BIO}
7.48		 LUNG}
-16.96		 CVRX}
-22.95		 OFIX}
-64.63		 BRKR}
-140.08		 GKOS}
-351.98		 SRDX}
-849.27		 MDT}
-4114.00
EV to Revenue 4.76 7/16 GKOS
24.09		 BSX
9.67		 CVRX
7.99		 SYK
7.08		 EW
6.50		 ABT
4.78		 ZBH
4.76		 MDT
4.24		 SRDX
4.13		 LUNG
3.99		 BRKR
3.32		 ITGR
2.92		 NUVA
2.37		 CNMD
2.32		 OFIX
1.02		 BIO
0.00

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions